White Paper: To Speciate or Not to Speciate? That Is the Question
June 7, 2017
Increasingly, we are being encouraged by consultants and regulators to identify environmental isolates beyond the genus level and down to the species level. This involves additional time, resource and expense – and to what end? What additional value does speciation provide to us, to the patient or indeed to the regulators?
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.